Alyeska Investment Group, L.P. Invitae Corp Transaction History

Alyeska Investment Group, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $1.12 Million - $4.73 Million	-525,000 Reduced 50.0%	525,000 $1.28 Million
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $1.06 Million - $2.64 Million	169,519 Added 19.25%	1,050,000 $8.37 Million
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $14.6 Million - $22.6 Million	559,753 Added 174.53%	880,481 $29.7 Million
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $4.27 Million - $7.36 Million	-129,272 Reduced 28.73%	320,728 $12.3 Million
Q1 2018 May 15, 2018	BUY	$4.69 - $10.05 $2.11 Million - $4.52 Million	450,000 New	450,000 $2.11 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.